Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28685917 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL5587992 | 0.97 | MAPT (0.40) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL8089705 | 0.97 | MAPT (0.40) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL20337312 | 0.95 | MAPT (0.39) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL5587603 | 0.95 | MAPT (0.39) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL20337311 | 0.95 | MAPT (0.39) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL20337307 | 0.91 | MAPT (0.37) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| Acetone SCHEMBL28791784 | 0.88 | ALDH1A1 (0.39) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| Acetone SCHEMBL28791786 | 0.88 | ALDH1A1 (0.39) | ALDH1A1MAPTPLA2G1BATG4BHPGD | |
| SCHEMBL27993966 | 0.84 | NR4A1 (0.54) | ALDH1A1HPGDKDM4EHSD17B10NR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562799-B1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11358914-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2022-06-14 | — | — | US | disclosed |
| US-20210214289-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2021-07-15 | — | — | US | disclosed |
| US-10793489-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-10-06 | — | — | US | disclosed |
| US-10604457-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-03-31 | — | — | US | disclosed |
| US-20200095178-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2020-03-26 | — | — | US | disclosed |
| US-10544070-B2 | Ethylene oligomerization process | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3562800-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2019-11-06 | — | — | EP | disclosed |
| EP-3562799-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2019-11-06 | — | — | EP | disclosed |
| US-20190276377-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-09-12 | — | — | US | disclosed |
| US-20190194089-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-06-27 | — | — | US | disclosed |
| WO-2018128861-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-07-12 | — | — | WO | disclosed |
| US-20180186708-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-07-05 | — | — | US | disclosed |
| US-20180186709-A1 | Ethylene Oligomerizaton Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-07-05 | — | — | US | disclosed |
| WO-2018125826-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180186708-A1 | Ethylene Oligomerization Processes | MAX, AP1M1, AP2M1 | SLC6A2 3311/4885ALDH1A1 4669/4885MAPT 922/4885 |
| US-20190276377-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | SLC6A2 3907/4885ALDH1A1 4471/4885MAPT 2760/4885 |
| US-20190194089-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | SLC6A2 3907/4885ALDH1A1 4471/4885MAPT 2760/4885 |
| US-10793489-B2 | Ethylene oligomerization processes | NOD2, AP1M1, AP2M1 | SLC6A2 3907/4885ALDH1A1 4471/4885MAPT 2760/4885 |
| US-10544070-B2 | Ethylene oligomerization process | NOD2, AP1M1, AP2M1 | SLC6A2 3944/4885ALDH1A1 4457/4885MAPT 2823/4885 |
| US-10604457-B2 | Ethylene oligomerization processes | EPS15, PICALM, AP2M1 | SLC6A2 4467/4885ALDH1A1 4824/4885MAPT 1342/4885 |
| US-20200095178-A1 | Ethylene Oligomerization Processes | NOD2, AP1M1, AP2M1 | SLC6A2 3907/4885ALDH1A1 4471/4885MAPT 2760/4885 |
| US-20180186709-A1 | Ethylene Oligomerizaton Processes | PICALM, EPS15, EPN1 | SLC6A2 4185/4885ALDH1A1 4825/4885MAPT 1506/4885 |
| US-20210214289-A1 | Ethylene Oligomerization Processes | MAX, AP1M1, AP2M1 | SLC6A2 3311/4885ALDH1A1 4669/4885MAPT 922/4885 |
| US-11358914-B2 | Ethylene oligomerization processes | MAX, AP1M1, AP2M1 | SLC6A2 3311/4885ALDH1A1 4669/4885MAPT 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.